Thursday, January 04, 2018 10:15 PM ET
Pieris Pharmaceuticals (PIRS) Insider Makes Significant Share Sale
There was a significant sale of shares of Pieris Pharmaceuticals by an insider today, as revealed in a form 4 document filed with the SEC. One insider — OrbiMed Advisors Llc, 10% Owner — disposed of 1,709,620 shares in the company having a market value of approximately $12,565,707. This is the first insider buy/sell trade in the past 90 days.
The number of buy-sell trades for Pieris Pharmaceuticals is close to that of the 279 member peer company average. The Bio Therapeutic Drugs peer group saw 308 buy/sell trades during this period for an average of 1.1 transactions per company. However, the number of shares per buy/sell trade transacted by Pieris Pharmaceuticals insiders is higher. Within the peer group there were 42,508,637 shares purchased and 37,288,749 shares sold with company insiders acquiring 26,231 shares on average.
The data sourced in composing and writing in this story eliminates all trading activity reported to the SEC that involves awards, options, exercise of derivative securities, company buy-backs, taxes, gifts, shares acquired via inheritance and tenders or exchange offers.
Using proprietary Natural Language Generation (NLG) technology, UpTick evaluates corporate insider filings reported to the SEC and creates real-time news and analysis to report the most significant insider transactions based on transaction type, size and historical trends.
For more information, contact UpTick at firstname.lastname@example.org. Copyright 2018 UpTick Data Technologies. All rights reserved.